Boditech Med has entered into a license agreement with SphingoTec
Worldwide licensing agreement signed to develop and offer penKid as test on Boditech's POCT immunoassay analyzers
Boditech Med has acquired the export license of Free T4 diagnostic kits
Targeting the global thyroid diagnostic market, which is estimated to be worth KRW 3.4 trillion by 2028
2022 Boditech Med Photo Contest - Winner Announcement
Congratulations to the Winners!
Who We Are
Heading to Global Top 10 In-Vitro diagnostic Company, Boditech Med Inc
We Boditech Med have been focusing on developing key technologies of immune-diagnosis and molecular diagnosis to provide reliable In-Vitro diagnostic solutions for everyone at anywhere, and anytime.
We are constantly striving to become a global In-Vitro diagnostic company realizing the value of respect for life. And We wish to finally improve quality of life across the world.